Spike Protein News and Research

RSS

Study discovers hidden mechanism behind rapid COVID variants

The SARS-CoV-2 virus that causes COVID has the unsettling ability of often generating variants of itself. Other viruses also mutate, but as SARS-CoV-2 quickly spread throughout the entire human population during the pandemic, killing millions, the virus' dynamic evolution posed a serious problem: it repeatedly challenged our bodies' immune response fighting the virus and hindered the process of getting updated vaccines ready.

23 Apr 2024

New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses

Researchers at Georgia Tech and the University of Wisconsin have created a broad-spectrum vaccine capable of defending against various SARS-CoV-2 variants and related bat coronaviruses.

17 Apr 2024

Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

Study introduces Reverse Vaccine Development as a strategic approach to identify correlates of protection early in vaccine development against antimicrobial-resistant pathogens, aiming to mitigate risks such as significant phase-III clinical trial failures.

7 Apr 2024

Language model uses powers of semantic representation to design more effective mRNA vaccines

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text -; the genetic code.

5 Apr 2024

Novel SARS-CoV-2 mutations found in floodwaters near homeless communities

Study highlights the detection of SARS-CoV-2 RNA and novel spike gene mutations in flood control channels affected by homeless populations, demonstrating the value of environmental surveillance in understanding public health dynamics.

4 Apr 2024

Wastewater surveillance reveals COVID-19 transmission patterns in unsheltered encampments

To better understand COVID-19's spread during the pandemic, public health officials expanded wastewater surveillance.

3 Apr 2024

Scientists develop trivalent vaccine offering broad protection against coronaviruses

Scientists have been searching for the optimal coronavirus vaccine since the Covid-19 pandemic started.

1 Apr 2024

Antibody discovery could explain mysteries about COVID-19 and long COVID

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID.

28 Mar 2024

Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

Study found that the antiviral molnupiravir affects the evolution of SARS-CoV-2 in immunocompromised patients, suggesting its use modifies viral mutation patterns and may impact viral evolution.

25 Mar 2024

Study reveals why COVID-19 antibodies fade quickly

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the antibody response following SARS-CoV-2 infection.

18 Mar 2024

Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines

Researchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.

11 Mar 2024

mRNA vaccines train T cells in waves, study shows

mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19).

9 Mar 2024

Metal organic frameworks enhance immune response in experimental vaccine

Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins.

6 Mar 2024

Researchers take important step toward genetic therapy for hereditary conditions

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.

5 Mar 2024

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.

1 Mar 2024

Unlocking coronavirus structure through M protein research

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

A new preprint reports significantly associated findings that may help predict severe long COVID and understand what causes it.

16 Feb 2024

Spike Protein News and Research

Study discovers hidden mechanism behind rapid COVID variants

New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses

Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

Language model uses powers of semantic representation to design more effective mRNA vaccines

Novel SARS-CoV-2 mutations found in floodwaters near homeless communities

Wastewater surveillance reveals COVID-19 transmission patterns in unsheltered encampments

Scientists develop trivalent vaccine offering broad protection against coronaviruses

Antibody discovery could explain mysteries about COVID-19 and long COVID

Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

Study reveals why COVID-19 antibodies fade quickly

Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines

mRNA vaccines train T cells in waves, study shows

Metal organic frameworks enhance immune response in experimental vaccine

Researchers take important step toward genetic therapy for hereditary conditions

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

Unlocking coronavirus structure through M protein research

Scientists uncover a new doorway for SARS-CoV-2 into human cells

Revolutionizing microscopy with affordable high-resolution techniques

Study reveals high prevalence of persistent COVID-19 infections in general population

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News